Bin Wen

Title: The Innovative Work of Inventor Bin Wen in Metabolic Disease Treatment

Introduction: Bin Wen, an accomplished inventor based in Shanghai, China, has made significant contributions to the field of metabolic disease treatment. With one patented invention, his work showcases innovative solutions to pressing health issues.

Latest Patents: Wen's notable patent, titled "Strain for preventing and treating metabolic diseases and use thereof," introduces a strain named SSYD-3, with an accession number CGMCC No. 14764. This innovative strain is superior to the existing strain, ATCC BAA835, exhibiting enhanced fermentation performance, storage stability, acid and bile resistance, and improved efficacy in treating metabolic diseases.

Career Highlights: Bin Wen has a remarkable career, having worked with reputable companies including Sph Sine Pharmaceutical Laboratories Co., Ltd. and the Shanghai Institute of Endocrine and Metabolic Diseases. His experiences in these institutions contribute to his expertise in the field and the development of his innovative solutions.

Collaborations: Throughout his career, Wen has collaborated with distinguished colleagues, including Guang Ning and Xin Ma. These partnerships enhance the collaborative spirit in scientific research and innovation, allowing for shared knowledge and progress in treating metabolic diseases.

Conclusion: Bin Wen's innovative contributions to the treatment of metabolic diseases through his patented strain SSYD-3 highlight his valuable role as an inventor. His commitment to improving health outcomes demonstrates the impact of innovation in the fields of medicine and biotechnology.